MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GH — Guardant Health, Inc. Common Stock
NasdaqGuardant Health, Inc. Common Stock
$177.80
+3.05(+1.75%)
- O
- 173.32
- H
- 179.17
- L
- 172.00
- V
- 1.65M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About GH
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateOct 4, 2018
Employees2,506
Stock ExchangeNasdaq
Ticker SymbolGH
Key Financial Statistics
| Market Cap | $23.86B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $61.00 - $183.51 |
| 52-Week Avg Volume | 2.29M |
| VWAP | $177.20 |
| Transactions | 28,598 |
| Total Recorded Bars | 2,009 days |